BioSpace News Archive

PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing regenerative tissue products and biomaterials, announced today that it will present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020 and the Cantor Virtual Global Healthcare Conference on September 15, 2020. A live audio webcast of the H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol, today announced enrollment of its first patient in GRATITUDE II, a randomized, double-blind, placebo-controlled, Phase 2 trial of miricorilant in obese patients with schizophrenia and long-standing antipsychotic-in

Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio” or the “Company”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today announced that management will present at the H.C. Wainwright 22nd Annual Global Investment Conference taking place virtually September 14 – 16, 2020. Jim Boyd, Chief Financial Officer, is scheduled to host a virtual pre

SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Phillip L. Gomez, SIGA’s Chief Executive Officer, will participate in a fireside chat at the Cantor Fitzgerald Virtual Global Healthcare Conference at 8:00 a.m. ET on Thursday, September 17, 2020. To access the live webcast, please visit the Company’s website at www.siga.com under the Events

DURECT Corporation (Nasdaq: DRRX) today announced that it will participate in the HC Wainwright 22nd Annual Global Investment Conference, Cantor Fitzgerald Virtual Global Healthcare Conference and Oppenheimer Fall Healthcare Life Sciences & MedTech Summit. HC Wainwright 22nd Annual Global Investment Conference Dat

Zoetis Inc. (NYSE:ZTS) will participate in the 18th Annual Morgan Stanley Healthcare Conference on Wednesday, Sept. 16, 2020. Kristin Peck, Chief Executive Officer, and Glenn David, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. They are scheduled to present virtually at 8:00 a.m. ET. Investors and other interested parties will be able to

Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases, today announced that Theresa Heggie, Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley Virtual 18 th Annual Global Healthcare Conferen

TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced Jason Ackerman, Chief Executive Officer and Executive Chairman of TerrAscend, Keith Stauffer, Chief Financial Officer, and Jason Wild, Chairman, will participate at two upcoming conferences

MaxCyte, a global cell-based therapies and life sciences company, today announced that CEO Doug Doerfler plans to present an overview of the company at the upcoming H.C. Wainright & Co 22nd Annual Global Investment Virtual Conference taking place September 14-16 , 2020. Details are as follows:

Bristol Myers Squibb (NYSE: BMY) today announced that the company will take part in a fireside chat at Morgan Stanley’s 18th Annual Global Healthcare Virtual Conference, which will be webcast on Thursday, September 17, 2020. Giovanni Caforio, M.D. , Chairman and Chief Executive Officer will answer questions about the co